Pronostic factors on recurrence and progression of superficial bladder cancer. Risk groups (Part II);Factores pronósticos en la recidiva y progresión del cáncer superficial vesical. Grupos de riesgo (Parte II)

Actas Urologicas Espanolas

Volumn 30, Issue 10, 2006, Pages 1009-1016

  Garcia Rodriguez J ^a,b   Fernandez Gomez J Ma ^a   Escaf Barmadah, S ^a   Jalon Monzon A ^a   Alvarez Mugica M ^a   Regadera Sejas, J ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b NONE   (Spain)

Author keywords

Bladder cancer; Risk groups; Superficial

Indexed keywords

ARTICLE; BLADDER TUMOR; DISEASE COURSE; HUMAN; PATHOLOGY; PROGNOSIS; RISK FACTOR; TIME; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE;

CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; HUMANS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK FACTORS; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 34247555074     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-4806(06)73577-X     Document Type: Article

References (25)

1. Ruiz Cerdá JL, Alfonso Gil R, Domenech Ferrando E, Pascual Bueno J, Vera Donoso CD, Martínez Jabaloyas J et al. Evolución temporal (1960-1990) de la mortalidad y la razón de masculinidad en España del cáncer vesical. Actas Urol Esp. 1995; 19(3):196-202.
2. a Ed. Editorial Médica Panamericana. 2004;4(76):2980-3043.
3. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD et al. Superficial bladder cancer: progression and recurrence. J Urol. 1983;130(6):1083-1086.
4. Pagano F, Garbeglio A, Milani C, Bassi P, Pegoraro V. Prognosis of bladder cancer. I. Risk factors in superficial transitional cell carcinoma. Eur Urol. 1987;13(3):145-149.
5. Chen SS, Chen KK, Lin AT, Chang YH, Wu HH, Hsu TH et al. The significance of tumor grade in predicting disease progression in stage Ta transitional cell carcinoma of the urinary bladder. Br J Urol. 1996;78(2):209-212.
6. Sánchez de la Muela P, Rosell D, Aguera L, De Castro F, Isa W, Robles JE et al. Multivariate analisis of progression in superficial bladder cancer. Br J Urol. 1993;71(3):284-289.
7. Raitanen MP, Nieminen P, Tammela TL. Impact of tumor grade, stage, number and size, and smoking and sex, on survival patients with transitional cell carcinoma of the bladder. Br J Urol. 1995;76(4):470-474.
8. Millán-Rodríguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Algaba F, Vicente-Rodríguez J. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol. 2000;164(3):680-684.
9. Oosterlinck W, Lobel B, Jakse G, Malmström PU, Stöckle M, Sternberg C. Guidelines on bladder cancer. Eur Urol. 2002;41(2):105-112.
10. Oosterlinck W. Guidelines on diagnosis and treatment of superficial bladder cancer. Minerva Urol Nefrol. 2004;56 (1):65-72.
11. Parmar MK, Freedman LS, Hargreave TB, Tolley DA. Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British medical research council subgroup on superficial bladder cancer (Urological cancer working party). J Urol. 1989;142(2 Pt 1):284-288.
12. Busto Catañón L, Sánchez Merino JM, Picallo Sánchez JA, Gelabert Mas A. Factores pronósticos clínicos en el cáncer superficial vesical. Arch Esp Urol. 2001;54(2):131-138.
13. Millán-Rodríguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodríguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol. 2000; 163(1):73-78.
14. Bohle A, Jocham D, Bock PR. Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. J Urol. 2003;169(1):90-95.
15. Takashi M, Murase T, Mizuno S, Hamajima N, Ohno Y. Multivariate evaluation of prognostic determinants in bladder cancer patients. Urol Int. 1987;42(5):368-374.
16. Ali-El-Dein B, Sarhan O; Hinev A, Ibrahiem el-HI, Nabeeh A, Ghoneim MA. Superficial bladder tumours: analysis of prognostic factors and construction of a predictive index. BJU Int. 2003;92(4):393-399.
17. Santos L, Amaro T, Costa C, Pereira S, Bento MJ, Lopes P, et al. Ki-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification. Int J Cancer. 2003;105(2):267-272.
18. Vicente R. Propuesta de seguimiento en Fundación Puigvert, J. Vicente R, G. Chéchile, J Salvador. Tumores vesicales superficiales Edit. Acción médica SA., 2000;215-223.
19. Kurth KH, Bouffioux C, Sylvester R, Van der Meijden APM, Oosterlinck W, Brausi M. Treatment of superficial bladder tumors: achievements and needs. The EORTC Genito-urinary. Group. Eur Urol. 2000;37(Suppl 3):1-9.
20. Herr HW, Badalament RA, Amato DA, Laudone VP, Fair WR, Whitmore WF Jr. Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression. J Urol. 1989;141(1): 22-29.
21. Fujii Y, Fukui I, Kihara K, Tsujii T, Kageyama Y, Oshima H. Late recurrente and progresión alter a long tumor-free period in prymary Ta and T1 bladder cancer. Eur Urol. 1999;36(4):309-313.
22. Andius P, Holmang S. Bacillus Calmette-Guerin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression. BJU Int. 2004;93(7):980-984.
23. Jiménez Cruz JF, Llopis Minués B, Vera Donoso CD. Cáncer vesical superficial primario. Factores pronósticos para recurrencia. Arch Esp Urol. 1990;43(Suppl 2):139-147.
24. Allard P, Bernard P, Fradet Y, Tetu B. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol. 1998;81(5):692-698.
25. Kurth KH, Denis L, Bouffioux C, Sylvester R, Debruyne FM, Pavone-Macaluso M et al. Factors affecting recurrence and progression in superficial bladder tumors. Eur J Cancer. 1995;31A(11):1840-1846.